Donglan Yuan

509 citations
35 papers · 353 indexed · h-index 12
Topics
Cancer-related molecular mechanisms research (11 papers)Circular RNAs in diseases (7 papers)Retinal Diseases and Treatments (3 papers)
Partner nations
ChinaUnited States

In The Last Decade

Donglan Yuan

32 papers receiving 353 citations

Peers

Donglan Yuan
Comparison fields: 5 of 58
  • Molecular Biology 175
  • Cancer Research 144
  • Immunology 43
  • Obstetrics and Gynecology 40
  • Ophthalmology 39
Replace T Kolben with:
T Kolben Germany
Aphrodite Nonni Greece
Jieping Hu China
Congkuan Song China
Ashwini Esnakula United States
William J. Hardman United States
B. Alexander Knight United States
Raafat Alameddine Lebanon
Xingdong Cai China
Adela Cimic United States
Donglan Yuan relative to T Kolben Germany T Kolben's profile →
Citations per field
00.5×2.8×
T Kolben · 1×
Citations per year

Countries citing papers authored by Donglan Yuan

Since Specialization
Citations

This map shows the geographic impact of Donglan Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donglan Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donglan Yuan more than expected).

Fields of papers citing papers by Donglan Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donglan Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donglan Yuan. The network helps show where Donglan Yuan may publish in the future.

Co-authorship network of co-authors of Donglan Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Donglan Yuan. A scholar is included among the top collaborators of Donglan Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donglan Yuan. Donglan Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 2
4 0
5 0
6 3
7 11
8
Exosomal lncRNA ATB Derived from Ovarian Cancer Cells Promotes Angiogenesis via Regulating miR-204-3p/TGFβR2 Axis
28
9 2
10 9
11 22
12 4
13 16
14 14
15 13
16 5
17 34
18 8
19 11
20 15

About Donglan Yuan

Donglan Yuan is a scholar working on Cancer Research, Obstetrics and Gynecology and Reproductive Medicine, having authored 35 papers that have together received 353 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (11 papers), Circular RNAs in diseases (7 papers) and Retinal Diseases and Treatments (3 papers). The work is most often cited by research in Cancer Research (144 citations), Obstetrics and Gynecology (40 citations) and Ophthalmology (39 citations). Donglan Yuan has collaborated with scholars based in China and United States. Frequent co-authors include Hua Qian, Dongqing Yuan, Qinghuai Liu, Aihua Huang, Junxing Huang, Lixin Zhang, Mei Lin, Hong Yu, Min Sha and Songtao Yuan. Their work appears in journals such as PLoS ONE, Ophthalmology and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026